Eribulin, trastuzumab, and pertuzumab as first-line therapy for patients with HER2-positive metastatic breast cancer: a phase II, multicenter, collaborative, open-label, single-arm clinical trial
Inoue, Kenichi, Ninomiya, Jun, Saito, Tsuyoshi, Okubo, Katsuhiko, Nakakuma, Takashi, Yamada, Hirofumi, Kimizuka, Kei, Higuchi, TohruLanguage:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-019-00755-x
Date:
March, 2019
File:
PDF, 597 KB
english, 2019